Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ShockPulse-SE Lithotripsy System

K-Number: K171024 · 2017-08-21

Decision Date2017-08-21
Product CodeFEO
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

ShockPulse-SE Lithotripsy System is a medical device manufactured by Cybersonics, Inc.. It received FDA 510(k) clearance on 2017-08-21 under approval number K171024. The device is classified under product code FEO. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ShockPulse-SE Lithotripsy System?

ShockPulse-SE Lithotripsy System is a medical device that received FDA 510(k) clearance on 2017-08-21. It is manufactured by Cybersonics, Inc.. The 510(k) number is K171024.

When was ShockPulse-SE Lithotripsy System approved by the FDA?

ShockPulse-SE Lithotripsy System received FDA 510(k) clearance on 2017-08-21, under approval number K171024.

What company makes ShockPulse-SE Lithotripsy System?

ShockPulse-SE Lithotripsy System is manufactured by Cybersonics, Inc..

What is the FDA product code for ShockPulse-SE Lithotripsy System?

The FDA product code for ShockPulse-SE Lithotripsy System is FEO.

Related Clinical Trials

Related Devices (Code: FEO)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.